Jeffrey S. Glenn serves as Executive at Eiger BioPharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey S. Glenn has executed 11 insider transactions totaling $733.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 22, 2022 involved purchasing 100,000 shares valued at $128.0K.
Jeffrey S. Glenn currently holds 182,355 shares of Eiger BioPharmaceuticals, Inc. (EIGR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey S. Glenn has been a net buyer of EIGR stock. They have purchased $733.3K and sold $0 worth of shares.
Jeffrey S. Glenn's most recent insider trade was on Dec 22, 2022, when they purchased 100,000 shares at $1.28 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 12, 2021 | EIGR | $0 | Award | 5,000 | $N/A | Discretionary |
| Aug 12, 2020 | EIGR | $51.5K | Purchase | 4,500 | $11.44 | Discretionary |
| Aug 12, 2020 | EIGR | $5.6K | Purchase | 500 | $11.28 | Discretionary |
| Aug 11, 2020 | EIGR | $57.5K | Purchase | 5,000 | $11.49 | Discretionary |
| Mar 16, 2020 | EIGR | $150.9K | Purchase | 30,000 | $5.03 | Discretionary |
| Mar 12, 2020 | EIGR | $0 | Award | 5,000 | $N/A | Discretionary |
| Sep 1, 2017 | EIGR | $142.9K | Purchase | 15,000 | $9.53 | Discretionary |
| Nov 18, 2016 | EIGR | $5.9K | Purchase | 460 | $12.90 | Discretionary |
| Nov 17, 2016 | EIGR | $190.9K | Purchase | 15,000 | $12.73 | Discretionary |